Instability of D145E, a Cardiac Troponin C Mutant Linked to Cardiomyopathy, Dictates Profound Changes in Ca2+ Regulation of Myofibrils at Increased Temperature  by Veltri, Tiago et al.
Tuesday, February 5, 2013 449athin filaments, which contain only one troponin for every tropomyosin, it is
the middle, fourth quasi-repeat of tropomyosin which interacts with TnI
C-terminus.
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Surface Immobilization of Cardiac Thin Filaments
Christopher Solis-Ocampo, Gi-Ho Kim, Maria Moutsoglou, John Robinson.
South Dakota State University, Brookings, SD, USA.
Our objective is to directly observe a single troponin (Tn) complex exchange
among its conformational substates. Here, we report experimental conditions
for immobilizing thin filaments (TF) to glass coverslips. TF were reconstituted
from F-actin, tropomyosin (cTm), and cTn, and were sonicated to produce
defined lengths. PEG-functionalized, neutravidin-coated coverslips were
prepared, and biotinylated gelsolin was sparsely immobilized to neutravidin.
TF were captured from solution in a flow chamber, and imaged under
oxygen scavenger solution. Labeled TF cTn(TnC-C89*AF488) (blue), cTm-
C190*AF546 (green), phalloidin*AF647 (red) were assessed by three-color
widefield fluorescence. Colocalization of blue, green, and red confirmed that
thin filaments contained Tn, Tm and actin. The number of dye-labeled cTn
per TF was quantified by the number of photo bleaching events per thin fila-
ment. We used photobleaching to confirm our ability to prepare TF with one
or fewer dye-labeled cTn per filament. These results demonstrate our ability
to reconstitute fluorescent-labeled thin filaments immobilized in PEG-coated
flow chambers.
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Regulation of myocardial contractility is influenced by numerous signaling
agents. One of the key methods for modification of cardiomyocyte function
is phosphorylation of cardiac troponin (cTn), the Ca2þ-dependent regulatory
switch that controls thin filament activation, by isoforms of protein kinase C
(PKC). PKC has been shown to phosphorylate the tropomyosin binding subunit
of cTn (cTnT) at Thr-195, Thr-199, Thr-204 and Thr-285 (rat cTnT). The effect
of these phosphorylations on cTn structure and dynamics remains largely un-
known. To ascertain the site specific effects of PKC phosphorylation of
cTnT on thin filament regulation, pseudo-phosphorylation of cTnT was com-
bined with Fo¨rster resonance energy transfer (FRET) to monitor the transition
between the Ca2þ and Mg2þ states of cTn. Single-cysteine cTnI mutants were
labeled with IAEDENS at either Cys-151 or Cys-167, and a single-cysteine
cTnC mutant was labeled at Cys-89 with DDPM. Different combinations of
mutant cTnT and fluorophore labeled cTnI and cTnC were then incorporated
into reconstituted thin filaments, which were subjected to calcium titrations,
time resolved FRET structural measurements, and stopped flow kinetic mea-
surements. Titrations showed a consistent pseudo-phosphorylation dependent
increase in pCa50 values, and kinetics experiments showed decreased rates
of Ca2þ dissociation in pseudo-phosphorylated mutants. Additionally, Mg2þ
distances between Cys-167 of cTnI and Cys-89 of cTnC were reduced in the
presence of pseudo-phosphorylation. Thus our results suggested that pseudo-
phosphorylation of cTnT leads to sensitization of the Ca2þ-dependent confor-
mational transitions involved in cTn regulatory switching. However, a prior
in situ study demonstrated a pseudo-phosphorylation dependent decrease in
EC50 (JBC vol. 278, pp. 35135-44). These results may suggest PKC mediated
phosphorylation of cTnT may represent a post-translational modification where
cTn regulatory switching is sensitized to Ca2þ, but also partially uncoupled
from Tm movement.
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Structural and Kinetic Effects of HCM Related Mutations R146G/Q and
R163W of Cardiac Troponin I on cTnI-cTnC Interaction within Reconsti-
tuted Thin Filament
Zhiqun Zhou, Daniel Rieck, King-Lun Li, Yexin Ouyang, Wen-Ji Dong.
Washington State University, pullman, WA, USA.
Mutations in cardiac troponin I (cTnI) that cause hypertrophic cardiomyopathy
(HCM) have been reported to change the contractility of cardiac myofilaments,
but the underlying molecular mechanism remains elusive. In this study, fluores-
cence spectroscopy was used to investigate the specific structural and kinetic
effects that HCM related cTnI mutations R146G/Q and R163W exert on
Ca2þ and myosin S1 dependent conformational transitions in cTn structure
while in the reconstituted thin filament. Fluorescently labeled mutants of
cTnC and cTnI were prepared for this purpose. Ca2þ-induced changes in inter-actions between cTnC and the inhibitory region (cTnIIR) and regulatory region
(cTnIRR) of cTnI were individually monitored using steady-state and time-
resolved Fo¨rster resonance energy transfer, and kinetics were determined using
FRET stopped-flow. It was found that R146G/Q and R163W all changed the
molecular distances between cTnC and cTnIIR and cTnIRR in unique and var-
ious ways. However, kinetic rates of conformational transitions induced by
Ca2þ-dissociation were universally slowed when R146G/Q and R163W were
present, except that R146Q sped up changes in the cTnIRRcTnC interaction.
This explained the universal trend of increased Ca2þ-sensitivity. Interestingly,
the kinetic rates of changes in the cTnIIRcTnC interaction were always slower
than that of the cTnIRRcTnC interaction, suggesting that the flycasting mech-
anism that normally underlies deactivation is preserved in spite of mutation.
Thus our results revealed that R146G/Q and R163W each impact regulatory
switching in their own unique way, but with a common kinetic outcome: the
slowing of thin filament deactivation. Furthermore, R146Q and R163W disrup-
ted the blocked state, causing the thin filament to behave as if it is in the fourth
‘‘pre-relax’’ state of regulation.
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Long-Range Transmission of Structural Instability due to the FHC Muta-
tion E180G in Coiled-Coil Tm is inhibited by an Interchain Disulfide Bond
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Previously we showed that the familial hypertrophic cardiomyopathy (FHC)
mutation in Tm, E180G, increased the trypsin cleavage rate at R133 and intro-
duced another cleavage site with a similar rate at K233 (Ly & Lehrer, 2012). To
understand how this mutation can produce this dynamically unstable hot spot
53 residues away, we introduced a disulfide crosslink (XL) at C190 and studied
its effect on limited trypsin digestion using MALDI MS and N-terminal
sequencing.
Trypsin digestions at 26 of native disulfide crosslinked (XL) aaTm, FHC
mutant D175N and WT, produced a XL heterodimer intermediate for all, con-
taining one cleaved chain at R133, XL to the full length chain (134-284/1-284)
(50 kDa) as well as the doubly cleaved XL homodimer (134-284/134-284)
(35 kDa). For XL E180G, however, another intermediate was also present
(169-284/1-284) (46 kDa). For native XL aaTm, the cleavage site at K168
was only observed at 40 where the middle of Tm is unfolded. In contrast to
uncrosslinked E180G, where cleavage occurred at residue 233, no cleavage
was observed at residue 233 for crosslinked E180G.
These results show: 1) that in addition to the increased destabilization near
R133 due to the Glu to Gly change at residue 180 in XL E180G, further desta-
bilization occurs in the region near residue 168; 2) the long-range destabiliza-
tion near residue K233 caused by the E180G FHC mutation is inhibited by the
intervening XL. This suggests that interchain dynamics is involved in propagat-
ing the local perturbation at 180G due to the mutation to the K233 region.
Supported by NIH HL 91162.
2302-Pos Board B321
Instability of D145E, a Cardiac Troponin C Mutant Linked to Cardiomy-
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We have shown previously that the hypertrophic cardiomyopathy mutant
HcTnC D145E lacks a-helical content compared to WT and confers greater
Ca2þ sensitivity on regulated thin filaments at 21C. We hypothesize that the
functional alterations are caused by protein instability. Here, using spectros-
copy and skinned-fiber assays, we examined the thermodynamic and functional
parameters of HcTnC D145E at physiologically relevant temperatures. Based
on circular dichroism, isolated D145E lost more of its secondary structure
than did WT at high temperatures (30-45C). Melting temperatures Tm for
WT and D145E were 71.850.2 vs 51.550.8C in Mg2þ (1 mM free)þ
EGTA and 78.250.2 vs 55.751.0C in 1 mM free Mg2þ, pCa 4. In 3M
urea (with and without Ca2þ/Mg2þ), D145E lost nearly all secondary structure
at 10C while WT began to unfold only at 45-50C. using bis-ANS, a fluores-
cent probe that binds to hydrophobic surfaces, we found that apoD145E was
structurally more open than WT, while Ca2þ, which opens hydrophobic
pockets in apoTnCWT, had no additional effect on D145E. The Ca2þ affinity
increment (DpCa50) (=pCa50D145E-pCa50WT) of isolated D145E vs WT
450a Tuesday, February 5, 2013double-labeled with 2-(4’-(2’’-iodoacetamido)phenyl)aminonaphthalene-6-
sulfonic acid (IAANS) was greater at higher temperatures, i.e. 0.11, 0.25 and
0.66 log units at 21, 30 and 45C respectively. In cardiac skinned fibers at
higher temperatures, Ca2þ binding affinity (-log Ca50) was further increased
for D145E (from pCa50 5.5550.01 at 15C to 6.3450.02 at 30C) than for
WT (pCa50 5.3950.01 at 15C to 5.9650.04 at 30C), so that DpCa50 mea-
sured at different temperatures increased in a linear fashion. Maximal tension
(P0) was markedly lower for D145E compared to WT at 30C. These data in-
dicate that D145E´s instability dictates its impaired function within the physio-
logical milieu. NIH-HL103840 (JRP)2303-Pos Board B322
Remote Ischemic Conditioning Restores Contractile defect Following
Ischemia by Reversing Ischemia-Induced Decreases in Phosphorylation
of Sarcomeric Proteins
Young S. Han, Ozgur Ogut.
Mayo Clinic College of Medicine, Rochester, MN, USA.
Non-invasive remote ischemic conditioning, repetitive brief ischemia of the
arm or leg through alternating inflation and deflation of a blood-pressure
cuff, has been demonstrated to produce cardioprotection in animal models
and in clinical studies. Our previous study using an in vivo rat ischemia model
demonstrated a decrease in maximal force per cross-sectional area (Fmax) and
the rate constant of force activation (kact) following flash photolysis of caged
Ca2þ (NP-EGTA), which correlated with a decrease in phosphorylation of tro-
ponin I (TnI) and myosin binding protein-C (MyBP-C), important regulators of
muscle contraction and targets of the cAMP-dependent protein kinase (PKA)
upon b-adrenergic receptor (b-AR) stimulation. Therefore, we hypothesized
that remote ischemic conditioning would mitigate the decrease in mechanical
function following acute ischemia by reversing ischemia-derived decreases
in phosphorylation of sarcomeric proteins and/or of PKA subunits. To test
this hypothesis, we examined Fmax, kact, and phosphorylation status of
MyBP-C, TnT, TnI, and PKA subunits in control, ischemic and conditioned
rat myocardia. Remote ischemic conditioning was simultaneously applied to
experimental rats undergoing 30-min acute myocardial ischemia with LAD
ligation by executing 3 cycles of 5-min inflation and deflation of a blood-
pressure cuff mounted on the left hind limb. Our data show that remote ische-
mic conditioning significantly blunts the reduction in Fmax (72.5 5 4.9 vs
53.7 5 3.4 vs 64.9 5 2.4 mN/mm2; control vs ischemic vs conditioned,
n=9; P< 0.05) and in kact (24.45 1.9 vs 19.15 1.0 vs 23.15 1.1 s
1; control
vs ischemic vs conditioned, n=9; P < 0.05), which correlates with reversal of
ischemia-derived decreases in phosphorylation of target proteins of PKA.
These data suggest that remote conditioning merits additional study for its
beneficial role in ischemia-induced myocardial dysfunction.2304-Pos Board B323
Mechanistic Understanding of the Involvement of MyBP-C Slow in the
Development of Distal Arthrogryposis
Maegen A. Ackermann, Minerva Contreras, Puja D. Patel,
Aikaterini Kontrogianni-Konstantopoulos.
University of Maryland, Baltimore, MD, USA.
Myosin Binding Protein-C (MyBP-C), expressed in striated muscles, is a thick
filament associated protein that plays important roles in thick filament assembly
and stabilization, and the modulation of actomyosin cross-bridges formation.
Several studies have implicated MyBP-C in the development of cardiac and
recently skeletal myopathies, underlining its importance in normal sarcomeric
function. Mutations in the slow skeletal isoform of MyBP-C (sMyBP-C) have
been causally linked to severe and lethal forms of arthrogryposis, a family of
neuromuscular diseases. Two missense mutations within MYBPC1, the gene
that encodes sMyBP-C, located within the NH2-terminal M-motif (W236R)
and the COOH-terminal immunoglobulin (Ig) C8 domain (Y856H) have
been linked to the development of distal arthrogryposis type-1 (DA-1), a skel-
etal muscle disorder characterized by contractures of the distal limbs. Here we
explore the molecular defects that underlie the development of DA-1. using
a combination of in vitro binding and motility assays, we show that the pres-
ence of the W236R mutation abolishes the ability of the NH2-terminus to mod-
ulate the formation of actomyosin cross-bridges, while the presence of the
Y856H mutation inhibits Ig domains C8-C10 from interacting with native
myosin filaments. Our findings therefore suggest that distinct mechanisms
may underlie the pathogenesis of DA-1 myopathy depending on the location
of the individual mutation within sMyBP-C. We are currently examining the
effects of overexpressing mutant sMyBP-C proteins carrying either the
W236R or the Y856H mutation in a sMyBP-C-null background, via in vivo
gene transfer. In summary, our studies are the first to provide a mechanistic
interpretation of the pathogenesis of distal arthrogryposis.2305-Pos Board B324
How Muscle Exploits the Steady State to Regulate Contraction
Henry G. Zot1, Javier E. Hasbun1, Nguyen Van Minh2.
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Activation of muscle requires myosin binding. The active state of muscle is sta-
bilized by high affinity rigor bonds at equilibrium but, the steady-state catalytic
cycle of myosin ATPase decreases the lifetime of the myosin interaction by
several orders of magnitude. Low myosin affinity could be a justification for
including Ca2þ binding states in a model of activation. Our work supports
a simple model for steady state activation, namely, the regulatory protein tropo-
myosin (Tm) exists in just two states, ground (C) and excited (M), separated by
an energy barrier which can be overcome by interaction with myosin. The elon-
gated shape of Tm allows for multiple potential myosin binding partners (Ui).
During its strong binding phase of the catalytic cycle, any one myosin (U1)
combines with C to form M by an equilibrium pathway. At time, t=0, M prob-
ability, PM=1. Although U1 most likely decays by a non-equilibrium rate (i.e.,
ATP binding), the lifetime of PM is constant. For t>0, before M decays to C,
interaction with Ui in the strong binding phase can restore PM=1. We show
that an analytical function (M function) is fully derived from the combination
of equilibrium and steady state pathways and the additional opportunities
(second chances) to restore PM=1 depend on the rate at which Ui transitions
into the strong binding phase. When Ca2þ is introduced as a mass action reg-
ulator of the U or C supply, the M function takes the general form of the
Hill equation, which is widely employed for fitting the steady state response
of muscle to Ca2þ. We show by simulations that stochastic events predicted
by a second chance mechanism are consistent with solutions to the M function.
Our results justify kinetic experiments that focus specifically on M.
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A hallmark of cardiac ischemia is decreased intracellular pH which can affect
a number of cellular processes. Such an acidic environment alters cardiac tro-
ponin (Tn) myofilament regulation to decrease the Ca2þ sensitivity of force
production. Tn also undergoes cardiac ischemic-induced AMPK troponin I
(TnI) Ser-150 phosphorylation. We recently characterized the effect of TnI
Ser-150 phosphorylation demonstrating it to increase myofilament Ca2þ sensi-
tivity and blunt TnI PKA phosphorylation-induced desensitization. The effect
of an acidic environment on Tn myofilament regulation in the presence of
the ischemic-induced TnI Ser-150 phosphorylation is unknown. In this study
we investigate the effect of pH on myofilament regulation in the presence of
TnI Ser-150 phosphorylation. Myofilament regulation was determined by mea-
suring troponin C Ca2þ binding properties at normal and acidic pH. Results
demonstrate acidic pH decreases steady-state Ca2þ binding to troponin C in
thin filaments reconstituted with either WT or Ser-150 pseudo-phosphorylated
TnI (Tn S150D) such that Tn S150D Ca2þ sensitivity at pH 6.5 is similar to WT
at pH 7. Furthermore, while Tn S150D slowed Ca2þ dissociation compared to
Tn WT at pH 7.0, decreasing the pH to 6.5 did not further alter isolated Tn
S150D Ca2þ dissociation indicating a lack of pH to modulate Tn Ca2þ disso-
ciation kinetics. Thin filament dissociation kinetics are ongoing. We conclude
that TnI Ser-150 phosphorylation imparts resistance to acidic pH induced myo-
filament Ca2þ desensitization similar to that present during ischemia without
alteration of Tn Ca2þ dissociation. Future investigations are aimed at examin-
ing the effect of TnI Ser-150 phosphorylation in the presence of TnI Ser-23/24
phosphorylation at low pH.
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Elevated levels of inorganic phosphate (Pi) and hydrogen ions (H
þ) are putative
agents of muscle fatigue. However, the molecular mechanisms underlying their
inhibitory action on the contractile proteins remains unclear. To gain mechanis-
tic insight into the effects of these ions on the myofilament function, we studied
their impact on the velocity-pCa relationship in an in vitro motility assay.
In this assay, actin filaments reconstituted with fast skeletal troponin (Tn)
and tropomyosin (Tm) moved on a coverslip surface coated with skeletal
myosin. At saturating Ca2þ (pCa5), decreasing the pH from 7.4 to 6.8 and
